Robert Kramer - 08 Feb 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role: President and CEO, Director
Signature: /s/ Jennifer Lynn Fox, Attorney-in-fact
Issuer symbol: EBS
Transactions as of: 08 Feb 2023
Net transactions value: -$65,508
Form type: 4
Filing time: 10 Feb 2023, 19:36:09 UTC
Previous filing: 02 Mar 2022
Next filing: 27 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EBS	Common Stock	Award	$0	+278	+0.24%	$0.000000	114,487	08 Feb 2023	Direct	F1
transaction	EBS	Common Stock	Tax liability	$65,508	-4,944	-4.3%	$13.25	109,543	08 Feb 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 16,961 shares of common stock, which is in excess of the 16,683 shares previously reported on February 25, 2020.
F2	Represents shares of common stock withheld to pay taxes.

Content

Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 16,961 shares of common stock, which is in excess of the 16,683 shares previously reported on February 25, 2020.

Represents shares of common stock withheld to pay taxes.